A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
To access this article, please choose from the options below
PII: S0944-7113(09)00037-3
doi:10.1016/j.phymed.2009.02.002
© 2009 Elsevier GmbH. All rights reserved.
